These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10512005)
41. Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder. Effect of water flow. Zusman RM; Keiser HR; Handler JS J Clin Invest; 1977 Dec; 60(6):1339-47. PubMed ID: 199620 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of prostaglandin synthesis and the action of vasopressin during extracellular volume expansion in the dog. Kövér G; Szemerédi K; Tost H Acta Physiol Hung; 1983; 61(3):169-84. PubMed ID: 6650187 [TBL] [Abstract][Full Text] [Related]
43. In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac. Kortenoeven ML; Trimpert C; van den Brand M; Li Y; Wetzels JF; Deen PM Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1395-401. PubMed ID: 22419689 [TBL] [Abstract][Full Text] [Related]
44. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931 [TBL] [Abstract][Full Text] [Related]
45. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes. Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976 [TBL] [Abstract][Full Text] [Related]
46. Influence of antidiuretic hormone on release of lysosomal hydrolase at mucosal surface of epithelial cells from urinary bladder. Pietras RJ; Seeler BJ; Szego CM Nature; 1975 Oct; 257(5526):493-5. PubMed ID: 1080837 [No Abstract] [Full Text] [Related]
47. [Effect of vasopressin on the osmotic permeability of the bladder wall in the frog and its content of cAMP, cGMP and inositol triphosphate]. Natochin IuV; Parnova RG; Reznik LV; Natochin MIu; Firsov DL Fiziol Zh SSSR Im I M Sechenova; 1989 May; 75(5):702-8. PubMed ID: 2548897 [TBL] [Abstract][Full Text] [Related]
48. [Acetylcholinesterase and the ADH-dependent transport of water in the amphibian bladder]. Bagrov IaIu; Manusova NB; Ostretsova IB Tsitologiia; 1991; 33(11):141-52. PubMed ID: 1819171 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of the antidiuretic effect of 1-deamino-8d-arginine vasopressin (DDAVP) by glibenclamide in water-loaded healthy subjects. Radó JP; Borbély L Endokrinologie; 1975 Sep; 66(1):88-93. PubMed ID: 817889 [TBL] [Abstract][Full Text] [Related]
50. [Intensification of the hydroosmotic effect of vasopressin with substances resistant to proteolysis]. Shakhmatova EI; Prutskova NP; Platé NA; Valuev LI; Natochin IuV Dokl Akad Nauk; 1998 Feb; 358(4):561-3. PubMed ID: 9541801 [No Abstract] [Full Text] [Related]
51. [Inhibition of protein kinase C with calphostin increases the hydroosmotic effect of vasopressin]. Natochin IuV; Shakhmatova EI Dokl Akad Nauk; 1993 Dec; 333(6):805-6. PubMed ID: 7509227 [No Abstract] [Full Text] [Related]
52. [Long-chained polyunsaturated fatty acids as modulators of the hydroosmotic action of vasopressin]. Pariova RG; Shakhmatova EI; Koroleva TA; Natochin IuV Dokl Akad Nauk; 1994 Aug; 337(5):690-2. PubMed ID: 7987232 [No Abstract] [Full Text] [Related]
53. Hyaluronate and hyaluronidase in the developing chick embryo kidney. Belsky E; Toole BP Cell Differ; 1983 Feb; 12(2):61-6. PubMed ID: 6402309 [TBL] [Abstract][Full Text] [Related]
54. Evidence for a two-site model of forskolin action in frog urinary bladder. Svelto M; Casavola V; Valenti G; Bourguet J Pflugers Arch; 1987 Aug; 409(4-5):486-91. PubMed ID: 3498147 [TBL] [Abstract][Full Text] [Related]
55. Hyaluronidase activity and hyaluronate content of the developing chick embryo heart. Orkin RW; Toole BP Dev Biol; 1978 Oct; 66(2):308-20. PubMed ID: 29813 [No Abstract] [Full Text] [Related]
56. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue. Morimoto K; Yamaguchi H; Iwakura Y; Morisaka K; Ohashi Y; Nakai Y Pharm Res; 1991 Apr; 8(4):471-4. PubMed ID: 1871041 [TBL] [Abstract][Full Text] [Related]
58. [The study of role of luminal receptors and prostaglandin E2 in modification of vasotocin hydroosmotic effect in the frog urinary bladder]. Shakhmatova EI; Prutskova NP; Natochin IuV Dokl Akad Nauk; 1999 Sep; 368(1):132-4. PubMed ID: 10546058 [No Abstract] [Full Text] [Related]
59. Hyaluronidase activity in lysosomes of bone tissue. Vaes G Biochem J; 1967 Jun; 103(3):802-4. PubMed ID: 6049405 [TBL] [Abstract][Full Text] [Related]
60. The origin of the hydroosmotic effect of arginine vasopressin: a hypothesis. Natochin YV; Shakhmatova EI Dokl Biol Sci; 2003; 389():96-8. PubMed ID: 12854399 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]